Aprea Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Aprea Therapeutics, Inc. (APRE) reported Basic Shares Outstanding (Weighted Average) of 53.48 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 53.48M shares, a 779.18% increase year-over-year.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 14.69M shares, a 145.01% increase year-over-year.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 7.70M shares, a 29.25% increase year-over-year.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 6.37M shares, a 7.29% increase year-over-year.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 6.54M shares, a 18.67% increase from fiscal 2024.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 5.51M shares, a 52.31% increase from fiscal 2023.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 3.62M shares, a 118.32% increase from fiscal 2022.
- Aprea Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 1.66M shares, a 55.69% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 53.48M shares 10-Q · filed 2026-08-12 | 34.19M shares 10-Q · filed 2026-08-12 | 25.29M shares derived: average of 3 quarters · filed 2026-08-12 | 20.56M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 14.69M shares 10-Q · filed 2026-05-13 | 11.19M shares derived: average of 2 quarters · filed 2026-05-13 | 9.59M shares derived: average of 3 quarters · filed 2026-05-13 | 8.71M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | 7.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 7.04M shares derived: average of 2 quarters · filed 2026-03-16 | 6.72M shares derived: average of 3 quarters · filed 2026-08-12 | 6.54M shares 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | 6.37M shares 10-Q · filed 2025-11-12 | 6.23M shares derived: average of 2 quarters · filed 2026-08-12 | 6.15M shares 10-Q · filed 2025-11-12 | 6.10M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 6.08M shares 10-Q · filed 2026-08-12 | 6.04M shares 10-Q · filed 2026-08-12 | 6.01M shares derived: average of 3 quarters · filed 2026-08-12 | 5.99M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | 5.99M shares 10-Q · filed 2026-05-13 | 5.98M shares derived: average of 2 quarters · filed 2026-05-13 | 5.96M shares derived: average of 3 quarters · filed 2026-05-13 | 5.96M shares derived: average of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | 5.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 5.95M shares derived: average of 2 quarters · filed 2026-03-16 | 5.94M shares derived: average of 3 quarters · filed 2026-03-16 | 5.51M shares 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | 5.94M shares 10-Q · filed 2025-11-12 | 5.94M shares derived: average of 2 quarters · filed 2025-11-12 | 5.36M shares 10-Q · filed 2025-11-12 | 4.95M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 5.94M shares 10-Q · filed 2025-08-12 | 5.07M shares 10-Q · filed 2025-08-12 | 4.62M shares derived: average of 3 quarters · filed 2025-08-12 | 4.40M shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 4.20M shares 10-Q · filed 2025-05-14 | 3.97M shares derived: average of 2 quarters · filed 2025-05-14 | 3.89M shares derived: average of 3 quarters · filed 2025-05-14 | 3.85M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 3.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | 3.74M shares derived: average of 2 quarters · filed 2025-03-25 | 3.73M shares derived: average of 3 quarters · filed 2025-03-25 | 3.62M shares 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | 3.74M shares 10-Q · filed 2024-11-07 | 3.73M shares derived: average of 2 quarters · filed 2024-11-07 | 3.58M shares 10-Q · filed 2024-11-07 | 3.35M shares derived: average of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | 3.73M shares 10-Q · filed 2024-08-12 | 3.50M shares 10-Q · filed 2024-08-12 | 3.22M shares derived: average of 3 quarters · filed 2024-08-12 | 2.85M shares derived: average of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | 3.26M shares 10-Q · filed 2024-05-14 | 2.96M shares derived: average of 2 quarters · filed 2024-05-14 | 2.55M shares derived: average of 3 quarters · filed 2024-05-14 | 2.20M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 2.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 2.20M shares derived: average of 2 quarters · filed 2024-03-26 | 1.84M shares derived: average of 3 quarters · filed 2024-03-26 | 1.66M shares 10-K · filed 2024-03-26 | ||||
| 2022-09-30 | 1.73M shares 10-Q · filed 2023-11-09 | 34.66M shares 10-Q · filed 2022-11-09 | 1.43M shares derived: average of 2 quarters · filed 2023-11-09 | 1.32M shares 10-Q · filed 2023-11-09 | 26.45M shares 10-Q · filed 2022-11-09 | -13.85M shares derived: average of 4 quarters · filed 2024-03-26 | ||
| 2022-06-30 | 1.13M shares 10-Q · filed 2023-08-10 | 22.66M shares 10-Q · filed 2022-08-12 | 1.11M shares 10-Q · filed 2023-08-10 | 22.28M shares 10-Q · filed 2022-08-12 | -19.04M shares derived: average of 3 quarters · filed 2024-03-26 | -8.97M shares derived: average of 4 quarters · filed 2024-03-26 | ||
| 2022-03-31 | 1.10M shares 10-Q · filed 2023-05-15 | 21.90M shares 10-Q · filed 2022-05-16 | -29.13M shares derived: average of 2 quarters · filed 2024-03-26 | -12.34M shares derived: average of 3 quarters · filed 2024-03-26 | -3.96M shares derived: average of 4 quarters · filed 2024-03-26 | |||
| 2021-12-31 | -59.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -19.06M shares derived: average of 2 quarters · filed 2024-03-26 | -5.64M shares derived: average of 3 quarters · filed 2024-03-26 | 1.06M shares 10-K · filed 2024-03-26 | 21.29M shares 10-K · filed 2022-03-15 | |||
| 2021-09-30 | 21.23M shares 10-Q · filed 2022-11-09 | 21.21M shares derived: average of 2 quarters · filed 2022-11-09 | 21.20M shares 10-Q · filed 2022-11-09 | 1.12M shares derived: average of 4 quarters · filed 2023-03-30 | ||||
| 2021-06-30 | 21.19M shares 10-Q · filed 2022-08-12 | 21.19M shares 10-Q · filed 2022-08-12 | -5.58M shares derived: average of 3 quarters · filed 2023-03-30 | 1.11M shares derived: average of 4 quarters · filed 2023-03-30 | ||||
| 2021-03-31 | 21.19M shares 10-Q · filed 2022-05-16 | -18.97M shares derived: average of 2 quarters · filed 2023-03-30 | -5.58M shares derived: average of 3 quarters · filed 2023-03-30 | |||||
| 2020-12-31 | -59.12M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -18.97M shares derived: average of 2 quarters · filed 2023-03-30 | 1.06M shares 10-K · filed 2023-03-30 | 21.13M shares 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | 21.19M shares 10-Q · filed 2021-11-08 | 21.12M shares 10-Q · filed 2021-11-08 | ||||||
| 2019-12-31 | 6.00M shares 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |